Citations (6)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (6)
PengYu Yang, Wei Kang, YaWen Pan, XianJun Zhao & Lei Duan. (2019) Overexpression of HOXC6 promotes cell proliferation and migration via MAPK signaling and predicts a poor prognosis in glioblastoma. Cancer Management and Research 11, pages 8167-8179.
Read now
Read now
Youngwoo Cho, Lara Milane & Mansoor M. Amiji. (2019) Genetic and epigenetic strategies for advancing ovarian cancer immunotherapy. Expert Opinion on Biological Therapy 19:6, pages 547-560.
Read now
Read now
Zhenghui Liu, Yingxue Gao & Xiong Li. (2019) Cancer epigenetics and the potential of epigenetic drugs for treating solid tumors. Expert Review of Anticancer Therapy 19:2, pages 139-149.
Read now
Read now
Yating Chen, Wenjie Guo, Junsheng Fan, Yuqing Chen, Xiaoli Zhang, Xin Chen & Peng Luo. (2017) The applications of liquid biopsy in resistance surveillance of anaplastic lymphoma kinase inhibitor. Cancer Management and Research 9, pages 801-811.
Read now
Read now
Prashant S. Kharkar. (2017) Cancer stem cell (CSC) inhibitors: a review of recent patents (2012-2015). Expert Opinion on Therapeutic Patents 27:7, pages 753-761.
Read now
Read now
Akihiro Nishi, Danny A Milner$suffix/text()$suffix/text(), Edward L Giovannucci, Reiko Nishihara, Andy S Tan, Ichiro Kawachi & Shuji Ogino. (2016) Integration of molecular pathology, epidemiology and social science for global precision medicine. Expert Review of Molecular Diagnostics 16:1, pages 11-23.
Read now
Read now